SA Asks: How will changes at FDA impact vaccine makers?
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Morsa Images Vaccine stocks have been under significant pressure in recent days following news that
BNTX
How Peter Marks’ FDA departure is impacting pharma, biotech stocks
by
Contributor since / Followers
Contributor since / Followers
2 weeks ago
Grandbrothers/iStock Editorial via Getty Images The abrupt resignation announcement that came late on Friday, March
Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Michael M. Santiago Pfizer (NYSE:PFE) and other pandemic-era favorites will be back in the investors’
Top FDA vaccine official resigns citing RFK Jr.’s ‘misinformation and lies’
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Luis Alvarez/DigitalVision via Getty Images The Food and Drug Administration’s top vaccine official, Peter Marks,
CureVac up 13% as court upholds validity of patent in BioNTech spat
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Matthias Hangst/Getty Images News CureVac (NASDAQ:CVAC) is up ~13% in after-hours trading Thursday after the
Pfizer drops after report on U.S. probe related to its COVID vaccine success
by
Contributor since / Followers
Contributor since / Followers
3 weeks ago
Alexandros Michailidis/iStock Editorial via Getty Images Pfizer (NYSE:PFE) shares fell on Wednesday after The Wall
CDC vaccine meeting, delayed under RFK Jr., is rescheduled
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
sshepard The CDC has rescheduled a key advisory committee meeting on vaccine experts to April
Former Texas congressman Burgess eyed as CDC director nominee – report
by
Contributor since / Followers
Contributor since / Followers
4 weeks ago
Kent Nishimura/Getty Images News The White House is reportedly considering former U.S. Rep. Michael Burgess
BioNTech GAAP EPS of ???1.08, revenue of ???1.19B
by
Contributor since / Followers
Contributor since / Followers
1 month ago
BioNTech press release (NASDAQ:BNTX): Q4 GAAP EPS of ???1.08. Revenue of ???1.19B (-19.6% Y/Y). Expects
FDA chief nominee Makary pledges to ‘review’ cancellation of vaccine panel meeting
by
Contributor since / Followers
Contributor since / Followers
1 month ago
Kayla Bartkowski/Getty Images News Days after the U.S. FDA cancelled an annual meeting to discuss